{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T08:58:12Z","timestamp":1789549092181,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","award":["31011"],"award-info":[{"award-number":["31011"]}],"id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009874","name":"Universit\u00e9 de Sherbrooke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009874","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.nmd.2022.11.003","type":"journal-article","created":{"date-parts":[[2022,11,13]],"date-time":"2022-11-13T18:00:55Z","timestamp":1668362455000},"page":"32-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Prevalence of urinary incontinence and other pelvic floor disorders in women with myotonic dystrophy type 1"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4541-1017","authenticated-orcid":false,"given":"Isabelle","family":"Fisette-Paulhus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Gagnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Morin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.nmd.2022.11.003_bib0001","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.nmd.2012.05.017","article-title":"Epidemiological surveillance of myotonic dystrophy type 1: A 25-year population-based study","volume":"22","author":"Mathieu","year":"2012","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"10.1016\/j.nmd.2022.11.003_bib0002","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/0092-8674(92)90154-5","article-title":"Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3\u2032 end of a transcript encoding a protein kinase family member","volume":"68","author":"Brook","year":"1992","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.nmd.2022.11.003_bib0003","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1007\/s00415-018-8898-4","article-title":"A 9-year follow-up study of quantitative muscle strength changes in myotonic dystrophy type 1","volume":"265","author":"Gagnon","year":"2018","journal-title":"J Neurol"},{"issue":"4","key":"10.1016\/j.nmd.2022.11.003_bib0004","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s11910-013-0340-9","article-title":"Daytime sleepiness and myotonic dystrophy","volume":"13","author":"Laberge","year":"2013","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.nmd.2022.11.003_bib0005","doi-asserted-by":"crossref","DOI":"10.1186\/s12883-015-0401-6","article-title":"Prevalence and correlates of apathy in myotonic dystrophy type 1","volume":"15","author":"Gallais","year":"2015","journal-title":"BMC Neurology"},{"issue":"10","key":"10.1016\/j.nmd.2022.11.003_bib0006","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.neurol.2016.08.003","article-title":"Unravelling the myotonic dystrophy type 1 clinical spectrum: A systematic registry-based study with implications for disease classification","volume":"172","author":"De Antonio","year":"2016","journal-title":"Revue Neurologique"},{"key":"10.1016\/j.nmd.2022.11.003_bib0007","series-title":"GeneReviews(\u00ae)","article-title":"Myotonic Dystrophy Type 1","author":"Bird","year":"1993"},{"issue":"7","key":"10.1016\/j.nmd.2022.11.003_bib0008","first-page":"415","article-title":"Is there a lower urinary tract dysfunction in patients with myotonic dystrophy?. [French]","volume":"37","author":"Renardel-Irani","year":"1994","journal-title":"Annales de Readaptation et de Medecine Physique"},{"key":"10.1016\/j.nmd.2022.11.003_bib0009","series-title":"5th International Consultation on Incontinence Paris, February 2012","author":"Abrams","year":"2012"},{"issue":"Suppl 5","key":"10.1016\/j.nmd.2022.11.003_bib0010","first-page":"S2","article-title":"Female pelvic floor anatomy: the pelvic floor, supporting structures, and pelvic organs","volume":"6","author":"Herschorn","year":"2004","journal-title":"Rev Urol"},{"key":"10.1016\/j.nmd.2022.11.003_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmd.2022.01.008","article-title":"Genitourinary and lower gastrointestinal conditions in patients with myotonic dystrophy type 1: A systematic review of evidence and implications for clinical practice","author":"Fisette-Paulhus","year":"2022","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"10.1016\/j.nmd.2022.11.003_bib0012","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1212\/CPJ.0000000000000531","article-title":"Consensus-based care recommendations for adults with myotonic dystrophy type 1","volume":"8","author":"Ashizawa","year":"2018","journal-title":"Neurol Clin Pract"},{"issue":"1","key":"10.1016\/j.nmd.2022.11.003_bib0013","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/nau.20870","article-title":"Fourth international consultation on incontinence recommendations of the international scientific committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence","volume":"29","author":"Abrams","year":"2010","journal-title":"Neurourol Urodyn"},{"issue":"Supplement 1","key":"10.1016\/j.nmd.2022.11.003_bib0014","first-page":"S200","article-title":"Lower urinary tract and bowel dysfunction in patients with myotonic dystrophy","volume":"1","author":"Vohanka","year":"2014","journal-title":"J Neuromuscul Dis"},{"issue":"2","key":"10.1016\/j.nmd.2022.11.003_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148264","article-title":"Gender as a Modifying Factor Influencing Myotonic Dystrophy Type 1 Phenotype Severity and Mortality: A Nationwide Multiple Databases Cross-Sectional Observational Study","volume":"11","author":"Dogan","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.nmd.2022.11.003_bib0016","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1212\/CPJ.0000000000000531","article-title":"Consensus-based care recommendations for adults with myotonic dystrophy type 1","volume":"8","author":"Ashizawa","year":"2018","journal-title":"Neurol Clinic Pract"},{"key":"10.1016\/j.nmd.2022.11.003_bib0017","first-page":"14","article-title":"Clinical and Genetic Characteristics of Childhood-onset Myotonic Dystrophy","author":"Stokes","year":"2019","journal-title":"Muscle & Nerve"},{"issue":"4","key":"10.1016\/j.nmd.2022.11.003_bib0018","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/nau.20041","article-title":"ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence","volume":"23","author":"Avery","year":"2004","journal-title":"Neurourol Urodyn"},{"issue":"3","key":"10.1016\/j.nmd.2022.11.003_bib0019","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0022-5347(05)00348-4","article-title":"The International Consultation on Incontinence Modular Questionnaire: www.iciq.net","volume":"175","author":"Abrams","year":"2006","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.nmd.2022.11.003_bib0020","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1067\/mob.2001.118659","article-title":"Psychometric evaluation of 2 comprehensive condition-specific quality of life instruments for women with pelvic floor disorders","volume":"185","author":"Barber","year":"2001","journal-title":"Am J Obst Gyn"},{"issue":"6","key":"10.1016\/j.nmd.2022.11.003_bib0021","first-page":"503","article-title":"Quality of life instruments for women with pelvic organ prolapse","volume":"32","author":"de Tayrac","year":"2003","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"issue":"4","key":"10.1016\/j.nmd.2022.11.003_bib0022","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/nau.20934","article-title":"Further validation of the short form versions of the Pelvic Floor Distress Inventory (PFDI) and Pelvic Floor Impact Questionnaire (PFIQ)","volume":"30","author":"Barber","year":"2011","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"10.1016\/j.nmd.2022.11.003_bib0023","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ajog.2004.12.025","article-title":"Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7)","volume":"193","author":"Barber","year":"2005","journal-title":"Am J Obst Gyn"},{"issue":"8","key":"10.1016\/j.nmd.2022.11.003_bib0024","first-page":"738","article-title":"Validation linguistique en fran\u00e7ais des versions courtes des questionnaires de sympt\u00f4mes (PFDI-20) et de qualit\u00e9 de vie (PFIQ-7) chez les patientes pr\u00e9sentant un trouble de la statique pelvienne","volume":"36","author":"de Tayrac","year":"2007","journal-title":"Development of a linguistically validated French version of two short-form, condition-specific quality of life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7) (English)"},{"issue":"5","key":"10.1016\/j.nmd.2022.11.003_bib0025","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/nau.20674","article-title":"Comparison of two questionnaires for assessing the severity of urinary incontinence: The ICIQ-UI SF versus the incontinence severity index","volume":"28","author":"Klovning","year":"2009","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"10.1016\/j.nmd.2022.11.003_bib0026","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/bju.13187","article-title":"Guideline of guidelines: urinary incontinence","volume":"117","author":"Syan","year":"2016","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.nmd.2022.11.003_bib0027","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/17474124.2020.1708718","article-title":"An approach to the diagnosis and management of Rome IV functional disorders of chronic constipation","volume":"14","author":"Aziz","year":"2020","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.nmd.2022.11.003_bib0028","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1053\/j.gastro.2016.02.032","article-title":"Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV","volume":"150","author":"Drossman","year":"2016","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.nmd.2022.11.003_bib0029","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1053\/j.gastro.2016.02.014","article-title":"Development and Validation of the Rome IV Diagnostic Questionnaire for Adults","volume":"150","author":"Palsson","year":"2016","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.nmd.2022.11.003_bib0030","doi-asserted-by":"crossref","first-page":"E852","DOI":"10.1212\/WNL.0000000000006948","article-title":"A large multicenter study of pediatric myotonic dystrophy type 1 for evidence-based management","volume":"92","author":"Lagrue","year":"2019","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.nmd.2022.11.003_bib0031","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s00192-016-3003-y","article-title":"An International Urogynecological Association (IUGA)\/International Continence Society (ICS) joint report on the terminology for female pelvic organ prolapse (POP)","volume":"27","author":"Haylen","year":"2016","journal-title":"Int Urogynecol J"},{"issue":"3","key":"10.1016\/j.nmd.2022.11.003_bib0032","first-page":"154","article-title":"Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies","volume":"32","author":"Meola","year":"2013","journal-title":"Acta Myol"},{"key":"10.1016\/j.nmd.2022.11.003_bib0033","article-title":"Urinary incontinence in women","volume":"3","author":"Aoki","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.nmd.2022.11.003_bib0034","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0090-4295(77)90297-7","article-title":"Integral storage and voiding reflexes: Neurophysiologic concept of continence and micturition","volume":"9","author":"Mahony","year":"1977","journal-title":"Urology"},{"issue":"7","key":"10.1016\/j.nmd.2022.11.003_bib0035","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/dmcn.12948","article-title":"Parent-reported multi-national study of the impact of congenital and childhood onset myotonic dystrophy","volume":"58","author":"Johnson","year":"2016","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"10.1016\/j.nmd.2022.11.003_bib0036","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00192-009-0976-9","article-title":"An International Urogynecological Association (IUGA)\/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction","volume":"21","author":"Haylen","year":"2010","journal-title":"Int Urogynecol J"},{"issue":"11","key":"10.1016\/j.nmd.2022.11.003_bib0037","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrurol.2014.286","article-title":"Contemporary concepts in the aetiopathogenesis of detrusor underactivity","volume":"11","author":"Osman","year":"2014","journal-title":"Nat Rev Urol"},{"issue":"7","key":"10.1016\/j.nmd.2022.11.003_bib0038","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.nmd.2019.05.009","article-title":"The prevalence of faecal incontinence in myotonic dystrophy type 1","volume":"29","author":"Petty","year":"2019","journal-title":"Neuromuscul Disord"},{"issue":"7","key":"10.1016\/j.nmd.2022.11.003_bib0039","doi-asserted-by":"crossref","first-page":"654","DOI":"10.3109\/00365529609009145","article-title":"Gastrointestinal symptoms in myotonic dystrophy","volume":"31","author":"Ronnblom","year":"1996","journal-title":"Scand J Gastroenterol"},{"issue":"4","key":"10.1016\/j.nmd.2022.11.003_bib0040","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/mus.26420","article-title":"The myotonic dystrophy experience: a North American cross-sectional study","volume":"59","author":"Hagerman","year":"2019","journal-title":"Muscle & Nerve"},{"issue":"4","key":"10.1016\/j.nmd.2022.11.003_bib0041","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1212\/WNL.0b013e318260cbe6","article-title":"Patient-reported impact of symptoms in myotonic dystrophy type 1 (PRISM-1)","volume":"79","author":"Heatwole","year":"2012","journal-title":"Neurology"},{"issue":"394","key":"10.1016\/j.nmd.2022.11.003_bib0042","article-title":"High Prevalence and Gender-Related Differences of Gastrointestinal Manifestations in a Cohort of DM1 Patients: A Perspective, Cross-Sectional Study","volume":"11","author":"Perna","year":"2020","journal-title":"Front Neurol"},{"issue":"4","key":"10.1016\/j.nmd.2022.11.003_bib0043","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/mus.26420","article-title":"The myotonic dystrophy experience: a North American cross-sectional study","volume":"59","author":"Hagerman","year":"2019","journal-title":"Muscle and Nerve"},{"issue":"3","key":"10.1016\/j.nmd.2022.11.003_bib0044","first-page":"179","article-title":"Pelvic Organ Prolapse","volume":"96","author":"Iglesia","year":"2017","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.nmd.2022.11.003_bib0045","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-016-0417-z","article-title":"Disease awareness in myotonic dystrophy type 1: an observational cross-sectional study","volume":"11","author":"Baldanzi","year":"2016","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"10.1016\/j.nmd.2022.11.003_bib0046","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/13697137.2018.1543263","article-title":"The prevalence of urinary incontinence","volume":"22","author":"Milsom","year":"2019","journal-title":"Climacteric"},{"issue":"5","key":"10.1016\/j.nmd.2022.11.003_bib0047","first-page":"97","article-title":"The self-reported prevalence and knowledge of urinary incontinence and barriers to health care-seeking in a community sample of Canadian women","volume":"3","author":"Taylor","year":"2013","journal-title":"Am J Med Sci"},{"issue":"6","key":"10.1016\/j.nmd.2022.11.003_bib0048","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.eururo.2006.09.019","article-title":"Population-Based Survey of Urinary Incontinence, Overactive Bladder, and Other Lower Urinary Tract Symptoms in Five Countries: Results of the EPIC Study","volume":"50","author":"Irwin","year":"2006","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.nmd.2022.11.003_bib0049","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1053\/j.gastro.2019.12.021","article-title":"Prevalence of Rome IV Functional Bowel Disorders Among Adults in the United States, Canada, and the United Kingdom","volume":"158","author":"Palsson","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nmd.2022.11.003_bib0050","series-title":"Incontinence: 5th International Consultation on Incontinence, Paris, February 2012","first-page":"15","article-title":"Epidemiology of urinary incontinence (UI) and other lower urinary tract symptoms (LUTS), pelvic organ prolapse (POP) and anal incontinence (AI)","author":"Milsom","year":"2013"},{"issue":"2","key":"10.1016\/j.nmd.2022.11.003_bib0051","first-page":"385","article-title":"Fecal Incontinence Diagnosed by the Rome IV Criteria in the United States, Canada, and the United Kingdom","volume":"18","author":"Whitehead","year":"2020","journal-title":"Clinic Gastroenterol Hepatol Offic Clinic Pract J Am Gastroenterol Assoc"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896622007052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896622007052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:13:23Z","timestamp":1760775203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896622007052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0960896622007052"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2022.11.003","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of urinary incontinence and other pelvic floor disorders in women with myotonic dystrophy type 1","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2022.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}